Related Experiment Video
Updated: Feb 13, 2026

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells
Published on: November 13, 2014
Differential mRNA expression of the main apoptotic proteins in normal and malignant cells and its relation to in
Andrea Vazanova1,2, Jana Jurecekova1,3, Tomas Balharek4
11Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin (JFM), Comenius University in Bratislava (CU), Mala Hora 4D, 03601 Martin, Slovak Republic.
Background:
Apoptosis plays an important role in the development and homeostasis of multicellular organisms and its deregulation may result in many serious diseases, including cancer. Now it is clear that some oncogenic mutations disrupt apoptosis, leading to tumour initiation, progression or metastasis. Here, expression of apoptotic genes in context of drug resistance was investigated.
Methods:
We examined total of 102 samples from leukemic patients (n = 60) and patients with solid tumours (n = 42). We used RT-PCR to determine the levels of mRNA expression and the in vitro chemoresistance of leukemic cells was evaluated using the MTT assay.
Results:
We found statistically significant increase in mRNA expression of all investigated proteins (p53, BAX, Bcl-2 and Bcl-XL) between the leukemia samples and leukocytes from healthy volunteers. We did not find any significant difference in mRNA levels among the solid tumour samples. Notably, we showed a significant positive correlation in both leukemic and solid tumour patient groups between p53 and BAX mRNA. We found that the highest values for the Bcl-2/BAX ratio were in solid tumours in comparison to leukemic cells or normal leukocytes. Moreover, we assessed the impact of p53 and BAX mRNA levels on the sensitivity of the leukemic cells to selected cytostatics.
Conclusions:
Elevated levels of p53 and BAX mRNA may indicate cellular response to possible changes in genomic DNA integrity associated with malignant transformation. We suggest that the BAX gene is regulated by the p53 protein but the initiation of apoptosis through the transcription activation of BAX is blocked by the high levels of Bcl-2. Given that the apoptosis resistance mechanisms are different among oncological patients as well as stages of identical malignancy cases, personalized and specific combination therapy is proposed to be more effective in clinical application.
Insights
Investigating apoptotic gene expression in cancer patients revealed elevated p53 and BAX mRNA in leukemia. High Bcl-2 levels appear to block apoptosis, suggesting personalized combination therapy for improved cancer treatment outcomes.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- Apoptosis is crucial for multicellular organism development and homeostasis.
- Deregulation of apoptosis is linked to severe diseases, including cancer.
- Oncogenic mutations can disrupt apoptosis, driving tumor initiation, progression, and metastasis.
Purpose of the Study:
- To investigate the expression of apoptotic genes in cancer patients.
- To explore the relationship between gene expression and drug resistance.
- To assess the impact of specific gene levels on chemoresistance.
Main Methods:
- Analysis of 102 samples from leukemia (n=60) and solid tumor (n=42) patients.
- Quantitative RT-PCR to measure mRNA expression levels of p53, BAX, Bcl-2, and Bcl-XL.
- In vitro chemoresistance evaluation of leukemic cells using the MTT assay.
Main Results:
- Statistically significant increase in p53, BAX, Bcl-2, and Bcl-XL mRNA in leukemia samples compared to healthy volunteers.
- No significant difference in mRNA levels observed among solid tumor samples.
- Positive correlation between p53 and BAX mRNA in both patient groups; highest Bcl-2/BAX ratio in solid tumors.
Conclusions:
- Elevated p53 and BAX mRNA may signal genomic DNA integrity changes during malignant transformation.
- p53 likely regulates BAX, but high Bcl-2 levels may inhibit p53-mediated apoptosis.
- Differential apoptosis resistance mechanisms necessitate personalized combination therapies for oncological patients.
Related Concept Videos
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Cell Specific Gene Expression
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Regulated mRNA Transport
Nuclear Export of mRNA

